Trial Profile
Objective assessment of fesoterodine for overactive bladder with benign prostatic hyperplasia
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2013
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 08 Jul 2013 New trial record